Management of cardiogenic shock

European Heart Journal

Volumn 36, Issue 20, 2015, Pages 1223-1230

  Thiele, Holger ^a   Ohman, E Magnus ^b   Desch, Steffen ^a   Eitel, Ingo ^a   De Waha, Suzanne ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Assist device; Heart failure; Myocardial infarction; Percutaneous coronary intervention; Shock; Treatment

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; HYPERTENSIVE FACTOR; INOTROPIC AGENT; FIBRINOLYTIC AGENT;

ACUTE HEART INFARCTION; ARTIFICIAL VENTILATION; CARDIOGENIC SHOCK; CORONARY ARTERY DISEASE; EVIDENCE BASED PRACTICE; EXTRACORPOREAL CIRCULATION; HEART MUSCLE REVASCULARIZATION; INDUCED HYPOTHERMIA; INTENSIVE CARE UNIT; INTRAAORTIC BALLOON PUMP; LEFT VENTRICULAR ASSIST DEVICE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; FORECASTING; HEART ASSIST DEVICE; HUMAN; INTENSIVE CARE; PERCUTANEOUS CORONARY INTERVENTION; PROCEDURES; PROSTHESIS DESIGN; SHOCK, CARDIOGENIC;

CRITICAL CARE; FIBRINOLYTIC AGENTS; FORECASTING; HEART-ASSIST DEVICES; HUMANS; HYPOTHERMIA, INDUCED; INTRA-AORTIC BALLOON PUMPING; MYOCARDIAL REVASCULARIZATION; PERCUTANEOUS CORONARY INTERVENTION; PLATELET AGGREGATION INHIBITORS; PROGNOSIS; PROSTHESIS DESIGN; SHOCK, CARDIOGENIC;

EID: 84928640275     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehv051     Document Type: Review

References (57)

1. Reynolds HR, Hochman JS. Cardiogenic shock. Current concepts and improving outcomes. Circulation 2008; 117: 686-697
2. Hochman JS, Buller CE, Sleeper LA, Boland J, Dzavik V, Sanborn TA, Godfrey E, White HD, Lim J, LeJemtel T. Cardiogenic shock complicating acute myocardial infarction- etiologies, management and outcome: a report from the SHOCK Trial Registry. J Am Coll Cardiol 2000; 36: 1063-1070
3. Aissaoui N, Puymirat E, Tabone X, Charbonnier B, Schiele F, Lefevre T, Durand E, Blanchard D, Simon T, Cambou J-P, Danchin N. Improved outcome of cardiogenic shock at the acute stage of myocardial infarction: a report from the USIK 1995, USIC 2000, and FAST-MI French Nationwide Registries. Eur Heart J 2012; 33: 2535-2543
4. Goldberg RJ, Spencer FA, Gore JM, Lessard D, Yarzebski J. Thirty-year trends (1975 to 2005) in the magnitude of, management of, and hospital death rates associated with cardiogenic shock in patients with acute myocardial infarction: a populationbased perspective. Circulation 2009; 119: 1211-1219
5. Jeger RV, Radovanovic D, Hunziker PR, Pfisterer ME, Stauffer JC, Erne P, Urban P. Ten-year incidence and treatment of cardiogenic shock. Ann Intern Med 2008; 149: 618-626
6. Thiele H, Allam B, Chatellier G, Schuler G, Lafont A. Shock in acute myocardial infarction: the Cape Horn for trials?. Eur Heart J 2010; 31: 1828-1835
7. Thiele H, Zeymer U, Neumann F-J, Ferenc M, Olbrich H-G, Hausleiter J, Richardt G, Hennersdorf M, Empen K, Fuernau G, Desch S, Eitel I, Hambrecht R, Fuhrmann J, Böhm M, Ebelt H, Schneider S, Schuler G, Werdan K. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med 2012; 367: 1287-1296
8. Katz JN, Stebbins AL, Alexander JH, Reynolds HR, Pieper KS, RuzylloW, Werdan K, Geppert A, Dzavik V, Van deWerf F, Hochman JS. Predictors of 30-day mortality in patients with refractory cardiogenic shock following acute myocardial infarction despite a patent infarct artery. Am Heart J 2009; 158: 680-687
9. Sleeper LA, Reynolds HR, White HD, Webb JG, Dzav?'k V, Hochman JS. A severity scoring system for risk assessment of patients with cardiogenic shock: a report from the SHOCK Trial and Registry. Am Heart J 2010; 160: 443-450
10. Thiele H, Zeymer U, Neumann F-J, Ferenc M, Olbrich H-G, Hausleiter J, deWaha A, Richardt G, Hennersdorf M, Empen K, Fuernau G, Desch S, Eitel I, Hambrecht R, Lauer B, Böhm M, Ebelt H, Schneider S, Werdan K, Schuler G. Intraaortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock. Final 12-month results of the randomised IntraAortic Balloon Pump in cardiogenic shock II (IABP-SHOCK II) Trial. Lancet 2013; 382: 1638-1645
11. Prondzinsky R, Unverzagt S, LemmH, Wegener NA, Schlitt A, Heinroth KM, Dietz S, Buerke U, Kellner P, Loppnow H, Fiedler MG, Thiery J, Werdan K, Buerke M. Interleukin-6, -7, -8 and -10 predict outcome in acute myocardial infarction complicated by cardiogenic shock. Clin Res Cardiol 2012; 101: 375-384
12. Link A, Pöss J, Rbah R, Barth C, Feth L, Selejan S, Böhm M. Circulating angiopoietins and cardiovascular mortality in cardiogenic shock. Eur Heart J 2013; 34: 1651-1662
13. den Uil CA, Lagrand WK, Van Der Ent M, Jewbali LS, Cheng JM, Spronk PE, Simoons ML. Impaired microcirculation predicts poor outcome of patients with acute myocardial infarction complicated by cardiogenic shock. Eur Heart J 2010; 31: 3032-3039
14. Hochman JS, Sleeper LA, Webb JG, Sanborn TA, White HD, Talley JD, Buller CE, Jacobs AK, Slater JN, Col J, McKinlay SM, LeJemtel TH. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. N Engl J Med 1999; 341: 625-634
15. Hochman JS, Sleeper LA, Webb JG, Dzavik V, Buller CE, Aylward PE, Col J, White HD. Early revascularization and long-Term survival in cardiogenic shock complicating acute myocardial infarction. JAMA 2006; 295: 2511-2515
16. Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, Falk V, Filippatos G, Hamm C, Head SJ, Juni P, Kappetein AP, Kastrati A, Knuuti J, Landmesser U, Laufer G, Neumann FJ, Richter DJ, Schauerte P, Sousa Uva M, Stefanini GG, Taggart DP, Torracca L, Valgimigli M, Wijns W, Witkowski A, Authors/Task Force m. 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 2014; 35: 2541-2619
17. Steg PG, James SK, Atar D, Badano LP, Lundqvist CB, Borger MA, Di Mario C, Dickstein K, Ducrocq G, Fernandez-Aviles F, Gershlick AH, Giannuzzi P, Halvorsen S, Huber K, Juni P, Kastrati A, Knuuti J, Lenzen MJ, Mahaffey KW, Valgimigli M, Van't Hof A, Widimsky P, Zahger D.ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2012; 33: 2569-2619
18. Webb JG, Lowe AM, Sanborn TA, White HD, Sleeper LA, Carere RG, Buller CE, Wong SC, Boland J, Dzavik V, Porway M, Pate G, Bergman G, Hochman JS. Percutaneous coronary intervention for cardiogenic shock in the SHOCK trial. J Am Coll Cardiol 2003; 42: 1380-1386
19. Sanborn TA, Sleeper LA, Webb JG, French JK, Bergman G, Parikh M, Wong SC, Boland J, Pfisterer M, Slater JN, Sharma S, Hochman JS. Correlates of one-year survival in patients with cardiogenic shock complicating acute myocardial infarction: angiographic findings from the SHOCK trial. J Am Coll Cardiol 2003; 42: 1373-1379
20. Mehta RH, Lopes RD, Ballotta A, Frigiola A, SketchMHJr, Bossone E, Bates ER. Percutaneous coronary intervention or coronary artery bypass surgery for cardiogenic shock and multivessel coronary artery disease?. Am Heart J 2010; 159: 141-147
21. Bauer T, Zeymer U, Hochadel M, Möllmann H, Weidinger F, Zahn R, Nef HM, Hamm CW, Marco J, Gitt AK. Use and outcomes of multivessel percutaneous coronary intervention in patients with acute myocardial infarction complicated by cardiogenic shock (from the EHS-PCI Registry). Am J Cardiol 2012; 109: 941-946
22. Van Der Schaaf RJ, Claessen BE, VisMM, Hoebers LP, KochKT, Baan J Jr, Meuwissen M, Engstrom AE, Kikkert WJ, Tijssen JGP, De Winter RJ, Piek JJ, Henriques JPS. Effect of multivessel coronary disease with or without concurrent chronic total occlusion on one-year mortality in patients treated with primary percutaneous coronary intervention for cardiogenic shock. Am J Cardiol 2010; 105: 955-959
23. Cavender MA, Milford-Beland S, Roe MT, Peterson ED, Weintraub WS, Rao SV. Prevalence, predictors, and in-hospital outcomes of non-infarct artery intervention during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction (from the National Cardiovascular Data Registry). Am J Cardiol 2009; 104: 507-513
24. Mylotte D, Morice M-C, Eltchaninoff H, Garot J, Louvard Y, Lefevre T, Garot P. Primary percutaneous coronary intervention in patients with acute myocardial infarction, resuscitated cardiac arrest, and cardiogenic shock. The role of primary multivessel revascularization. JACC: Cardiovasc Intv 2013; 6: 115-125
25. Zeymer U, Hochadel M, Thiele H, Andresen D, Schühlen H, Brachmann J, Elsässer A, Gitt A, Zahn R. Immediate multivessel percutaneous coronary intervention versus culprit lesion intervention in patients with acute myocardial infarction complicated by cardiogenic shock: results of the ALKK-PCI registry. EuroIntervention 2014; doi: 10.4244/EIJY4214M4208-4204
26. Yang JH, Hahn JY, Song PS, Song YB, Choi SH, Choi JH, Lee SH, Jeong MH, Choi DJ, Kim YJ, GwonHC. Percutaneous coronary intervention for nonculprit vessels in cardiogenic shock complicating ST-segment elevation acute myocardial infarction. Crit Care Med 2014; 47: 17-25
27. Parodi G, Xanthopoulou I, Bellandi B, Valenti R, Gkizas V, Migliorini A, Karanikas S, Abbate R, Antoniucci D, Alexopoulos D. Ticagrelor crushed tablets administration in STEMI patients: The Mashed Or Just Integral Tablets of ticagrelOr (MOJITO) study. Eur Heart J 2014; 35 (Abstract Supplement): 1030
28. Zeymer U, Vogt A, Zahn R, Weber MA, Tebbe U, Gottwik M, Bonzel T, Senges J, Neuhaus KL. Predictors of in-hospital mortality in 1333 patients with acute myocardial infarction complicated by cardiogenic shock treated with primary percutaneous coronary intervention (PCI). Eur Heart J 2004; 25: 322-328
29. Antoniucci D, Valenti R, Migliorini A, Moschi G, Trapani M, DovelliniEV, Bolognese L, SantoroGM. Abciximab therapy improves survival in patients with acute myocardial infarction complicated by early cardiogenic shock undergoing coronary artery stent implantation. Am J Cardiol 2002; 90: 353-357
30. Tousek P, Rokyta R, Tesarova J, Pudil R, Belohlavek J, Stasek J, Rohac F, Widimsky P. Routine upfront abciximab versus standard periprocedural therapy in patients undergoing primary percutaneous coronary intervention for cardiogenic shock: The PRAGUE-7 Study. An open randomized multicentre study. Acute Card Care 2011; 13: 116-122
31. De Backer D, Biston P, Devriendt J, Madl C, Chochrad D, Aldecoa C, Brasseur A, Defrance P, Gottignies P, Vincent JL. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med 2010; 362: 779-789
32. Asfar P, Meziani F, Hamel J-F, Grelon F, Megarbane B, Anguel N, Mira J-P, Dequin P-F, Gergaud S, Weiss N, Legay F, Le Tulzo Y, Conrad M, Robert R, Gonzalez F, Guitton C, Tamion F, Tonnelier J-M, Guezennec P, Van Der Linden T, Vieillard-Baron A, Mariotte E, Pradel G, Lesieur O, Ricard J-D, Hervé F, du Cheyron D, Guerin C, Mercat A, Teboul J-L, Radermacher P. High versus low bloodpressure target in patients with septic shock. N Engl J Med 2014; 370: 1583-1593
33. Unverzagt S, Wachsmuth L, Hirsch K, Thiele H, Buerke M, Haerting J, Werdan K, Prondzinsky R. Inotropic agents and vasodilator strategies for acute myocardial infarction complicated by cardiogenic shock or low cardiac output syndrome. Cochrane Database Syst Rev 2014
34. Werdan K, Ruß M, Buerke M, Delle-Karth G, Geppert A, Schöndube FA. Cardiogenic shock due to myocardial infarction: diagnosis, monitoring and treatment - A German-Austrian S3 Guideline. Dtsch Arztebl Int 2012; 109: 343-351
35. Cheng JM, den Uil CA, Hoeks SE, Van Der Ent M, Jewbali LSD, Van Domburg RT, Serruys PW. Percutaneous left ventricular assist devices vs. intra-Aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-Analysis of controlled trials. Eur Heart J 2009; 30: 2102-2108
36. Cheng R, Hachamovitch R, Kittleson M, Patel J, Arabia F, Moriguchi J, Esmailian F, Azarbal B. Complications of extracorporeal membrane oxygenation for treatment of cardiogenic shock and cardiac arrest: A meta-Analysis of 1, 866 adult patients. Ann Thorac Surg 2014; 97: 610-616
37. Rao SV, Jollis JG, Harrington RA, Granger CB, Newby LK, Armstrong PW, Moliterno DJ, Lindblad L, Pieper K, Topol EJ, Stamler JS, Califf RM. Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. JAMA 2004; 292: 1555-1562
38. Hunt BJ. Bleeding and coagulopathies in critical care. N Engl J Med 2014; 370: 847-859
39. Villanueva C, Colomo A, Bosch A, Concepción M, Hernandez-Gea V, Aracil C, Graupera I, Poca M, Alvarez-Urturi C, Gordillo J, Guarner-Argente C, Santaló M, Muñiz E, Guarner C. Transfusion strategies for acute upper gastrointestinal bleeding. N Engl J Med 2013; 368: 11-21
40. Hazinski MF, Nolan JP, Billi JE, Bottiger BW, Bossaert L, De Caen AR, Deakin CD, Drajer S, Eigel B, Hickey RW, Jacobs I, Kleinman ME, Kloeck W, Koster RW, Lim SH, Mancini ME, Montgomery WH, Morley PT, Morrison LJ, Nadkarni VM, O'Connor RE, Okada K, Perlman JM, Sayre MR, Shuster M, Soar J, Sunde K, Travers AH, Wyllie J, Zideman D. Part 1: Executive summary: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations. Circulation 2010; 122: S250-S275
41. Stegman BM, Newby LK, Hochman JS, Ohman EM. Post-myocardial infarction cardiogenic shock is a systemic illness in need of systemic treatment: is therapeutic hypothermia one possibility?. J Am Coll Cardiol 2012; 59: 644-647
42. Stretch R, Sauer CM, Yuh DD, Bonde P. National trends in the utilization of shortterm mechanical circulatory support: incidence, outcomes, and cost analysis. J Am Coll Card 2014; 64: 1407-1415
43. Thiele H, SmallingRW, Schuler G. Percutaneous left ventricular assist devices in cardiogenic shock. Eur Heart J 2007; 28: 2057-2063
44. Werdan K, Gielen S, EbeltH, Hochman JS. Mechanical circulatory support in cardiogenic shock. Eur Heart J 2014; 35: 156-167
45. Prondzinsky R, Unverzagt S, Russ M, Lemm H, Swyter M, Wegener N, Buerke U, Raaz U, Ebelt H, Schlitt A, Heinroth K, Haerting J, Werdan K, Buerke M. Hemodynamic effects of intra-Aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP shock trial. Shock 2012; 37: 378-384
46. O'Gara PT, Kushner FG, Ascheim DD, Casey DE, Chung MK, De Lemos JA, Ettinger SM, Fang JC, Fesmire FM, Franklin BA, Granger CB, Krumholz HM, Linderbaum JA, Morrow DA, Newby LK, Ornato JP, Ou N, Radford MJ, Tamis-Holland JE, Tommaso CL, Tracy CM, Woo YJ, Zhao DX. 2013 ACCF/AHA Guideline for the management of ST-elevation myocardial infarction: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2013; 127: e362-e425
47. Sjauw KD, Engstrom AE, VisMM, Van Der Schaaf RJ, Baan J Jr, Koch KT, De Winter RJ, Piek JJ, Tijssen JGP, Henriques JPS. A systematic review and meta-Analysis of intra aortic balloon pump therapy in ST-elevation myocardial infarction: should we change the guidelines?. Eur Heart J 2009; 30: 459-468
48. TheTRIUMPHInvestigators. Effect of Tilarginine Acetate in patients with acutemyocardial infarction and cardiogenic shock. The TRIUMPH Randomized Controlled Trial. JAMA 2007; 297: 1657-1666
49. Abdel-Wahab M, Saad M, Kynast J, Geist V, Sherif MA, Richardt G, Toelg R. Comparison of hospital mortality with intra-Aortic balloon counterpulsation insertion before versus after primary percutaneous coronary intervention for cardiogenic shock complicating acute myocardial infarction. Am J Cardiol 2010; 105: 967-971
50. Cheng JM, Van Leeuwen MA, De Boer SP, Wai MC, den Uil CA, Jewbali LS, Van Geuns RJ, Kardys I, Van Domburg RT, Boersma E, Zijlstra F, Akkerhuis KM. Impact of intra-Aortic balloon pump support initiated before versus after primary percutaneous coronary intervention in patients with cardiogenic shock from acute myocardial infarction. Int J Cardiol 2013; 168: 3758-3763
51. Patel MR, Smalling RW, Thiele H, Barnhart HX, Zhou Y, Chandra P, Chew D, Cohen M, French J, Perera D, Ohman EM. Intra-Aortic balloon counterpulsation and infarct size in patients with acute anterior myocardial infarction without shock: The CRISP AMI Randomized Trial. JAMA 2011; 306: 1329-1337
52. Engstrom AE, Cocchieri R, Driessen AH, Sjauw KD, Vis MM, Baan J, De Jong M, Lagrand WK, Van Der Sloot JA, Tijssen JG, De Winter RJ, De Mol BA, Piek JJ, Henriques JP. The Impella 2.5 and 5.0 devices for ST-elevation myocardial infarction patients presenting with severe and profound cardiogenic shock: the Academic Medical Center intensive care unit experience. Crit Care Med 2011; 39: 2072-2079
53. O'NeillWW, Theodore Schreiber T, Wohns DH, Rihal C, Naidu SS, Civitello AB, Dixon SR, Massaro JM, Maini B, Ohman ME. The current use of Impella 2.5 in acute myocardial infarction complicated by cardiogenic shock: Results from the USpella Registry. J Interv Cardiol 2014; 27: 1-11
54. Abrams D, Combes A, Brodie D. Extracorporeal membrane oxygenation in cardiopulmonary disease in adults. J Am Coll Card 2014; 63: 2769-2778
55. Sheu JJ, Tsai TH, Lee FY, Fang HY, Sun CK, Leu S, Yang CH, Chen SM, Hang CL, Hsieh YK, Chen CJ, Wu CJ, Yip HK. Early extracorporeal membrane oxygenatorassisted primary percutaneous coronary intervention improved 30-day clinical outcomes in patients with ST-segment elevation myocardial infarction complicated with profound cardiogenic shock. Crit Care Med 2010; 38: 1810-1817
56. Beurtheret S, Mordant P, Paoletti X, Marijon E, Celermajer DS, Leger P, Pavie A, Combes A, Leprince P. Emergency circulatory support in refractory cardiogenic shock patients in remote institutions: a pilot study (the cardiac-RESCUE program). Eur Heart J 2013; 34: 112-120
57. Thiele H, Vranckx P, Schuler G. Cardiogenic shock. In: Eeckhout E, Serruys PW, WijnsW, Vahanian A, Van Saambeck M, De Palma R (eds), Percutaneous Interventional Cardiovascular Medicine The PCR-EAPCI Textbook. Paris: Europa Organisation; 2012. pp. 1-36